UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Environmental chemicals causing chronic kidney disease identified
Researchers at Seoul National University Boramae Hospital have identified e...
by Lee Han-soo
|
2020-06-08 15:14
라인
Covid-19 fight at critical juncture amid slackening tension
Korea’s new virus cases fell below 40 on Sunday from above 50 in the two pr...
by Shim Hyun-tai
|
2020-06-08 14:52
라인
‘Give KCDC real power, not just bigger title’
“It will be a powerless unit with the essential tasks taken away.” This is ...
by Song Soo-youn
|
2020-06-08 13:53
라인
Kainos nears end of HIV drug’s clinical trials in China
Kainos Medicine said Friday it has completed the administration of a human ...
by Shim Hyun-tai
|
2020-06-05 17:40
라인
AMC in partial closure after Covid-19 patient’s visit
Asan Medical Center (AMC), one of the “Big Five” hospitals in Korea, said F...
by Shim Hyun-tai
|
2020-06-05 17:39
라인
Rinvoq joins competition among JAK inhibitors
AbbVie Korea has obtained approval for rheumatoid arthritis treatment Rinvo...
by Kim Yun-mi
|
2020-06-05 16:16
라인
Korea mired in whack-a-mole game with Covid-19
Korea’s fight against Covid-19 increasingly looks like a whack-a-mole game,...
by Shim Hyun-tai
|
2020-06-05 16:07
라인
‘Alecensa beat crizotinib as treatment of ALK-positive NSCLC’
Over the past decade, the first-generation tyrosine kinase inhibitor (TKI) ...
by Kim Yun-mi
|
2020-06-05 14:53
라인
[ASCO 2020 ⑥] Alteogen confirms safety, efficacy of HER2 breast cancer therapy
Alteogen said that its antibody-drug conjugate (ADC) ALT-P7 for patients wi...
by Shim Hyun-tai
|
2020-06-04 17:35
라인
IVI ties up with SNUH for clinical trial of Covid-19 vaccine
The International Vaccine Institute (IVI) and Seoul National University Hos...
by Lee Han-soo
|
2020-06-04 17:04
라인
Huons’ dry eye drop scores German nod for clinical trial
Huons said Thursday that the German Federal Institute for Drugs and Medical...
by Shim Hyun-tai
|
2020-06-04 16:25
라인
[ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform
Lunit has become Korea’s only AI-based medical image analytics company to p...
by Lee Han-soo
|
2020-06-04 16:25
라인
[Special] ‘Healthcare policies fail to support long-term fight against Covid-19’
Five months have passed since the nation started a war against the new coro...
by Song Soo-youn/Kim Eun-young
|
2020-06-04 15:55
라인
‘Blood test can detect Alzheimer’s early’
Local researchers said they have clinically proven how to diagnose Alzheime...
by Park Gi-taek
|
2020-06-04 15:40
라인
Greater Seoul remains jittery over sporadic, silent spreads
Korea’s new Covid-19 cases have remained between 30 and 40 over the past fe...
by Shim Hyun-tai
|
2020-06-04 14:38
라인
MedPacto to test Vactosertib for treating NSCLC
MedPacto has applied for phase 2 clinical trials concerning the combined us...
by Lee Han-soo
|
2020-06-04 12:43
라인
Korea to spend ₩1 trillion on fight against infectious diseases
The Ministry of Health and Welfare said Wednesday that 1.05 trillion won ($...
by Shim Hyun-tai
|
2020-06-03 18:18
라인
Dupixent to provide new treatment options for asthma patients
Sanofi-Aventis Korea said Wednesday it would enter the local asthma drug ma...
by Lee Han-soo
|
2020-06-03 17:54
라인
[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe
MedPacto said the combination of its small molecule TGF-B inhibitor, Vactos...
by Shim Hyun-tai
|
2020-06-03 17:20
라인
New plasma-based method found to treat refractory blood cancer
A new method has been found to treat chronic myelogenous leukemia, a type o...
by Lee Han-soo
|
2020-06-03 16:29
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top